-
Published 4/1/2026
Barmettler G, Leonard S, Giannakou A, Park KU, Smith CE, Mittendorf EA, King TA, Kantor O. ASO Visual Abstract: Breast Cancer Presentation and Treatment Patterns in Sexual and Gender Minorities. Ann Surg Oncol. 2026 Apr; 33(4):3405-3406. PMID: 41572120.
-
Published 6/2/2023
Olivier T, Smith CEP, Haslam A, Addeo A, Prasad V. Quality of life in the adjuvant setting: A meta-analysis of US Food and Drug Administration approved anti-cancer drugs from 2018 to 2022. J Cancer Policy. 2023 Sep; 37:100426. PMID: 37270063.
-
Published 9/10/2022
Smith CEP, Marcom PK, Mitri Z, Ko NY. Predictors of long-term durable response in de novo HER2-positive metastatic breast cancer and the real-world treatment experience at two institutions. Breast Cancer Res Treat. 2022 Nov; 196(1):215-220. PMID: 36087190.
-
Published 6/2/2022
Abd El-Salam MA, Smith CEP, Pan CX. Insights on recent innovations in bladder cancer immunotherapy. Cancer Cytopathol. 2022 Sep; 130(9):667-683. PMID: 35653623.
-
Published 5/3/2021
Smith CEP, Prasad V. Assessment of New Molecular Entities Approved for Cancer Treatment in 2020. JAMA Netw Open. 2021 05 03; 4(5):e2112558. PMID: 34047795.